Abcam given boost by rabbit antibody

China was a trail-blazer as its turnover grew just short of 30%.

What's up Doc? RabMAb, a suite of rabbit monoclonal antibodies, was in huge demand

Abcam PLC (LON:ABC), one of the world’s largest suppliers of antibodies used in research, said revenue and gross profit margins were in line with market forecasts.

Catalogue sales growth was 10.7% in the first half of the Cambridge group’s financial year with RabMAb, a suite of rabbit monoclonal antibodies, in huge demand.

China was a trail-blazer as its turnover grew just short of 30%.

For the year, Abcam expects turnover to increase by 10% on a constant currency basis and 30.4% on a reported basis. 

"We have maintained revenue momentum delivering more than twice market revenue growth in the period,” said chief executive Alan Hirzel.

“Our award-winning web site, unique products and fast service enable Abcam to better serve researchers to achieve their mission faster.

“Overall, we continue to make good progress against our strategic and investment objectives and continue to see growth opportunities for Abcam."

Quick facts: Abcam

Price: 1291 GBX

Market: AIM
Market Cap: £2.66 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Southern Gold active on the ground in South Korea with multiple rigs and...

Southern Gold Limited's (ASX:SAU) managing director Simon Mitchell tells Proactive London's Andrew Scott they're looking to become recognised as the go-to name for exploration in South Korea.  ''We're now 100% focused on South Korea and I think that's been well received by the market to...

6 hours, 50 minutes ago


Holding(s) in Company

1 day, 9 hours ago

Abcam Capital Markets Event

1 week, 1 day ago

Result of AGM

1 week, 2 days ago

Director/PDMR Shareholding

2 weeks, 2 days ago

Total Voting Rights

3 weeks ago

2 min read